Liver Disease and Oxycodone Use

Primary Recommendation

• The European Association for the Study of the Liver (EASL) recommends avoiding oxycodone in patients with end-stage liver disease, and instead suggests paracetamol, morphine, and hydromorphone for pain control in this population 1

Why Oxycodone Is Problematic in Liver Disease

• Oxycodone has a longer half-life, lower clearance, and greater potency for respiratory depression in patients with liver cirrhosis compared to those with normal liver function 1
• The blood concentrations of oxycodone metabolites vary unpredictably in hepatic impairment, making it difficult to estimate analgesic effects 1

If Oxycodone Must Be Used (Not Recommended)

• Initiate at 50% or less of the standard dose with extended dosing intervals (1.5- to 2-fold increase in interval) 1
• The Korean practice guidelines specify that oral oxycodone should be initiated at lower doses in cirrhotic patients 1

Preferred Alternatives for Pain Management

• Fentanyl is the preferred opioid for patients with liver disease, as it produces no toxic metabolites and its blood concentration remains stable even in severe hepatic dysfunction 1, 2
• Hydromorphone has a stable half-life even in liver dysfunction and is metabolized by conjugation, which is more predictable than oxidative metabolism 1, 2

Critical Monitoring Parameters

• Assess Child-Pugh score (bilirubin, albumin, PT/INR, ascites, encephalopathy) to stratify severity of liver disease 2
• Monitor for signs of excessive sedation, respiratory depression, and worsening encephalopathy 2

Common Pitfalls to Avoid

• Avoid codeine and tramadol completely due to unpredictable metabolism and high risk of adverse effects 2